Literature DB >> 11254588

Essential role for cellular phosphoglucomutase in virulence of type 3 Streptococcus pneumoniae.

G G Hardy1, A D Magee, C L Ventura, M J Caimano, J Yother.   

Abstract

Synthesis of the Streptococcus pneumoniae type 3 capsule requires the pathway glucose-6-phosphate (Glc-6-P) --> Glc-1-P --> UDP-Glc --> UDP-glucuronic acid (UDP-GlcUA) --> (GlcUA-Glc)(n). The UDP-Glc dehydrogenase and synthase necessary for the latter two steps, and essential for capsule production, are encoded by genes (cps3D and cps3S, respectively) located in the type 3 capsule locus. The phosphoglucomutase (PGM) and Glc-1-P uridylyltransferase activities necessary for the first two steps are derived largely through the actions of cellular enzymes. Homologues of these enzymes, encoded by cps3M and cps3U in the type 3 locus, are not required for capsule production. Here, we show that cps3M and cps3U also are not required for mouse virulence. In contrast, nonencapsulated isolates containing defined mutations in cps3D and cps3S were avirulent, as were reduced-capsule isolates containing mutations in pgm. Insertion mutants that lacked PGM activity were avirulent in both immunologically normal (BALB/cByJ) and immunodeficient (CBA/N) mice. In contrast, a mutant (JY1060) with reduced PGM activity was avirulent in the former but had only modestly reduced virulence in the latter. The high virulence in CBA/N mice was not due to the lack of antibodies to phosphocholine but reflected a growth environment distinct from that found in BALB/cByJ mice. The reduced PGM activity of JY1060 resulted in enhanced binding of complement and antibodies to surface antigens. However, decomplementation of BALB/cByJ mice did not enhance the virulence of this mutant. Suppressor mutations, only some of which resulted in increased capsule production, increased the virulence of JY1060 in BALB/cByJ mice. The results suggest that PGM plays a critical role in pneumococcal virulence by affecting multiple cellular pathways.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254588      PMCID: PMC98160          DOI: 10.1128/IAI.69.4.2309-2317.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Reciprocal capsular transformations of pneumococci.

Authors:  A W RAVIN
Journal:  J Bacteriol       Date:  1959-03       Impact factor: 3.490

2.  The Significance of Pneumococcal Types.

Authors:  F Griffith
Journal:  J Hyg (Lond)       Date:  1928-01

3.  Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection.

Authors:  H M Schrager; J G Rheinwald; M R Wessels
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

4.  Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H.

Authors:  C Neeleman; S P Geelen; P C Aerts; M R Daha; T E Mollnes; J J Roord; G Posthuma; H van Dijk; A Fleer
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene.

Authors:  J Yother; G L Handsome; D E Briles
Journal:  J Bacteriol       Date:  1992-01       Impact factor: 3.490

6.  Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae.

Authors:  A J Szalai; D E Briles; J E Volanakis
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

7.  Genetic and molecular characterization of capsular polysaccharide biosynthesis in Streptococcus pneumoniae type 3.

Authors:  J P Dillard; J Yother
Journal:  Mol Microbiol       Date:  1994-06       Impact factor: 3.501

8.  Characterization of the locus encoding the Streptococcus pneumoniae type 19F capsular polysaccharide biosynthetic pathway.

Authors:  J K Morona; R Morona; J C Paton
Journal:  Mol Microbiol       Date:  1997-02       Impact factor: 3.501

9.  Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae.

Authors:  M J Crain; W D Waltman; J S Turner; J Yother; D F Talkington; L S McDaniel; B M Gray; D E Briles
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

10.  The serotype of type Ia and III group B streptococci is determined by the polymerase gene within the polycistronic capsule operon.

Authors:  D O Chaffin; S B Beres; H H Yim; C E Rubens
Journal:  J Bacteriol       Date:  2000-08       Impact factor: 3.490

View more
  37 in total

1.  Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae.

Authors:  Melanie Abeyta; Gail G Hardy; Janet Yother
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

2.  The Pneumococcal Serotype 15C Capsule Is Partially O-Acetylated and Allows for Limited Evasion of 23-Valent Pneumococcal Polysaccharide Vaccine-Elicited Anti-Serotype 15B Antibodies.

Authors:  Brady L Spencer; Anukul T Shenoy; Carlos J Orihuela; Moon H Nahm
Journal:  Clin Vaccine Immunol       Date:  2017-08-04

3.  Pneumolysin, PspA, and PspC contribute to pneumococcal evasion of early innate immune responses during bacteremia in mice.

Authors:  Lisa R Quin; Quincy C Moore; Larry S McDaniel
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

4.  Initiation and synthesis of the Streptococcus pneumoniae type 3 capsule on a phosphatidylglycerol membrane anchor.

Authors:  Robert T Cartee; W Thomas Forsee; Janet Yother
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

5.  The capsular polysaccharide of Staphylococcus aureus is attached to peptidoglycan by the LytR-CpsA-Psr (LCP) family of enzymes.

Authors:  Yvonne Gar-Yun Chan; Hwan Keun Kim; Olaf Schneewind; Dominique Missiakas
Journal:  J Biol Chem       Date:  2014-04-21       Impact factor: 5.157

6.  Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells.

Authors:  Sven Hammerschmidt; Sonja Wolff; Andreas Hocke; Simone Rosseau; Ellruth Müller; Manfred Rohde
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

7.  Predicted functions and linkage specificities of the products of the Streptococcus pneumoniae capsular biosynthetic loci.

Authors:  David M Aanensen; Angeliki Mavroidi; Stephen D Bentley; Peter R Reeves; Brian G Spratt
Journal:  J Bacteriol       Date:  2007-08-31       Impact factor: 3.490

8.  Identification of additional loci associated with antibody response to Mycobacterium avium ssp. Paratuberculosis in cattle by GSEA-SNP analysis.

Authors:  Marcello Del Corvo; Mario Luini; Alessandra Stella; Giulio Pagnacco; Paolo Ajmone-Marsan; John L Williams; Giulietta Minozzi
Journal:  Mamm Genome       Date:  2017-09-01       Impact factor: 2.957

9.  Biochemical activities of Streptococcus pneumoniae serotype 2 capsular glycosyltransferases and significance of suppressor mutations affecting the initiating glycosyltransferase Cps2E.

Authors:  David B A James; Kanupriya Gupta; Jocelyn R Hauser; Janet Yother
Journal:  J Bacteriol       Date:  2013-10-04       Impact factor: 3.490

10.  Engineering of carbon distribution between glycolysis and sugar nucleotide biosynthesis in Lactococcus lactis.

Authors:  Ingeborg C Boels; Michiel Kleerebezem; Willem M de Vos
Journal:  Appl Environ Microbiol       Date:  2003-02       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.